VaccinesNews.net

Vaccines Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

The U.S. Food and Drug Administration ( FDA ) has approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty, for th ...


The JCVI ( Joint Committee on Vaccination and Immunisation ) has reviewed the evidence on vaccinating children aged 12 to 15 who do not have underlying health conditions that put them at increased ris ...


The U.S. Food and Drug Administration ( FDA ) has approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty, for th ...


At the time of this report, over 127,892 people across the UK have died within 28 days of a positive test for coronavirus ( COVID-19 ). All vaccines and medicines have some side effects. These side ...


Since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination ( Pfizer-BioNTech and Moderna ), particularly in adolescents a ...


EMA’s human medicines committee ( CHMP ) has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty ( Pfizer / BioNTech ) to include use in children aged 12 to 15. The va ...


The FDA ( U.S. Food and Drug Administration ) has expanded the emergency use authorization ( EUA ) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 ( COVID-19 ) ...


EMA’s safety committee ( PRAC ) has concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen. PRAC has also ...


EMA’s safety committee, PRAC, has concluded its preliminary review of a signal of blood clots in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting of 18 March 2021. ...


The FDA ( U.S. Food and Drug Administration ) has issued an emergency use authorization ( EUA ) for the third vaccine for the prevention of coronavirus disease 2019 ( COVID-19 ) caused by severe acute ...


EMA ( European Medicines Agency ) has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 ( COVID-19 ) in people from 18 yea ...


The COVID-19 pandemic has caused significant morbidity and mortality throughout the world, as well as major social, educational and economic disruptions. There is an urgent global need for effective ...


All reports of suspected adverse reactions with fatal outcome following COVID-19 vaccination are carefully assessed. The reports have suggested that common adverse reactions to mRNA ( messenger RNA ) ...


During December 14–23, 2020, after administration of 1,893,360 first doses of Pfizer-BioNTech COVID-19 vaccine ( 1,177,527 doses in females, 648,327 doses in males, and 67,506 doses missing sex ), rep ...


The safety of Comirnaty was evaluated in participants 16 years of age and older in 2 clinical studies that included 21,744 participants that have received at least one dose of Comirnaty. In Study 2, ...